Leading scientific researchers from the University of Oxford have warned that “the antiviral medication hydroxychloroquine is being ‘discarded prematurely’ and could still have benefit against COVID-19”, potentially saving tens of thousands of lives. Studies taken place to date have sought to treat patients who have already caught the virus, however, experts say it may still be able to stop people from getting infected in the first place. Both the BBC and the PharmaTimes report on the matter. The Oxford University-led trial is aiming to enrol 40,000 frontline workers around the world. Investigators hope the large-scale, double-blind randomised study will show
A document no longer available from the U.S. Food and Drug Administration regarding “Emergency Use Authorization” of potential COVID-19 treatments appears to suggest that hydroxychloroquine satisfies the criteria for the classification, but would stand in the way of lucrative other drugs, and a vaccine. The possible treatment, shunned by the mainstream media and Big Tech, has far-ranging champions from Yale epidemiologists to frontline doctors to President Trump. Despite this support, corroborated by scientific studies, the medical establishment under the auspices of Dr. Anthony Fauci have refused to grant hydroxychloroquine “Emergency Use Authorization” (EUA). July 29th documents from a Food and
Ohio health officials have reversed a rule blocking doctors’ ability to prescribe hydroxychloroquine, which many including President Trump allege may be a treatment for coronavirus. According to the Associated Press: The Ohio pharmacy board has rescinded a rule prohibiting the prescription of a malaria drug for use by patients with COVID-19. At issue is the prescribing of the drug hydroxychloroquine, whose effectiveness for the coronavirus has been widely questioned. On Wednesday, the pharmacy board banned its use as a coronavirus treatment, noting that the Food and Drug Administration previously revoked the emergency use of the drug. The FDA “made this
Anti-malarial hydroxychloroquine significantly reduces the death rate of COVID-19 patients, despite efforts from the media and scientific establishment to pour scorn on what has become known around the world as the “Trump drug”. The Detroit News reported on Thursday: A Henry Ford Health System study shows the controversial anti-malaria drug hydroxychloroquine helps lower the death rate of COVID-19 patients, the Detroit-based health system said Thursday. Officials with the Michigan health system said the study found the drug “significantly” decreased the death rate of patients involved in the analysis. The study analyzed 2,541 patients hospitalized among the system’s six hospitals between March 10 and
As the numbers of infected and dead coronavirus patients continue to tick up, we’ve begun to hear of hydroxychloroquine, a well-known anti-viral drug used for years to treat malaria, Lyme disease, and rheumatoid arthritis (RA). Chloroquine is FDA-approved and has been for many years. It is available and inexpensive (as low as 3 cents per pill for hydroxychloroquine). There appears to be some evidence that this is effective in treating COVID-19. Three medical studies have confirmed that in using chloroquine to treat the virus, one hundred percent of patients treated have been cured, in as little as six days. No